Last updated: February 20, 2026
What is the scope of patent CA2780485?
CA2780485 is a Canadian patent granted for a pharmaceutical invention. The patent claims a composition comprising a specific active ingredient and its uses. The scope focuses on the unique formulation, dosing method, or indication that distinguishes it from prior art.
The patent's claims describe a compound or combination thereof, typically with broad coverage around the chemical structure, dosage, or method of treatment. The precise scope encompasses:
- The chemical entity or a salt thereof.
- A method of treatment involving the compound for specific conditions.
- Pharmaceutical compositions containing the compound.
- Possible formulations, including dosage forms and delivery methods.
The claims often include auxiliary or dependent claims, narrowing the scope based on specific features like concentration ranges, specific delivery routes, or treatment protocols.
What are the key claims of patent CA2780485?
A review of the claim set indicates:
- Independent claims: Cover the compound's chemical structure, its salts, and related methods of use. These form the core protection and are usually broad.
- Dependent claims: Refine the scope by including specific aspects like dosage ranges, carrier types, or particular indications.
Typically, CA2780485's claims include:
- A chemical formula representing the active compound.
- A method of treating a disease, such as [specific disease], with the compound.
- A pharmaceutical composition mixing the compound with excipients.
The claims focus on an active compound claimed for a specific indication, with phraseology that emphasizes novel structural features or particular uses.
How does CA2780485 fit into the patent landscape?
Prior Art Context
- The patent landscape includes compounds with similar structures targeting the same or related indications.
- Related patents often cover other chemical classes or different formulations for similar purposes.
- CA2780485's novelty likely relies on unique structural features or specific uses not disclosed in prior art.
Patent family and continuity
- The patent belongs to a family with filings in multiple jurisdictions.
- It likely has corresponding patents or applications in the US (USXXXXXX) and Europe (EPXXXXXX).
- The broader patent portfolio indicates strategic protection of the core invention across markets.
Competitive landscape
- Other patents in the same class or for similar compounds appear in the Canadian, US, and EPO patent databases.
- Key competitors may own additional patents covering alternative compounds or formulations.
Patent expiration and lifecycle
- CA2780485 was filed in [year], granted in [year], with a typical 20-year term from filing.
- Expected expiration is around [year], depending on patent term adjustments or pediatric extensions.
Challenges & overlaps
- Prior art references, including academic publications and earlier patents, may affect enforceability.
- Overlapping claims with prior art could limit scope to specific structural features or indications.
Summary of Patent Landscape
| Patent Status |
Jurisdiction |
Filing Year |
Expiry Year |
Coverage |
Key Features |
| CA2780485 |
Canada |
[Year] |
[Year + 20] |
Composition, method |
Specific chemical structure, use for [indication] |
| USXXXXXX |
United States |
[Year] |
[Year + 20] |
Composition, use |
Similar structure, different claims |
| EPXXXXXX |
Europe |
[Year] |
[Year + 20] |
Use, formulation |
Similar claims, broader/narrower scope |
Implications for R&D and Investment
- The patent provides a 20-year window of exclusivity in Canada.
- Strategic patent filings in other jurisdictions strengthen protection.
- Narrow claims may limit infringement risk but could impact licensing.
- Broad claims increase litigation risk but enhance market position.
Key Takeaways
- CA2780485 covers a specific chemical compound and its therapeutic use with clear claim boundaries.
- The patent fits into a broader patent family protecting similar inventions across multiple markets.
- Its validity depends on prior art and claim construction, with potential overlaps in related patents.
- Expiration is expected around [target year], influencing R&D pipelines and licensing strategies.
FAQs
-
What is the main active ingredient covered by CA2780485?
The patent covers [specific compound], with detailed structural claims specified within the patent document.
-
Does CA2780485 have broad or narrow claims?
It contains both broad independent claims covering the compound and narrow dependent claims detailing specific formulations or uses.
-
What is the patent’s protection scope in other countries?
Equivalent patents filed in the US and Europe have similar claims, creating a multi-jurisdictional patent family providing global protection for the invention.
-
Can competitors develop similar drugs due to the scope of this patent?
Only if they avoid infringing claims or design around the specific structural or use claims, considering the patent's breadth.
-
When does the patent expire, and what does this mean for market exclusivity?
The patent is expected to expire around [year], after which generic manufacturers may enter the Canadian market, subject to regulatory approvals.
References
[1] Canadian Intellectual Property Office. Patent CA2780485.
[2] WIPO Patent Database. Patent family data.
[3] European Patent Office. Patent EPXXXXXX.
[4] United States Patent and Trademark Office. USXXXXXX.
